J Neurovirol. 2000 Feb;6(1):25-32. Unique Identifier : AIDSLINE
Neurological damage in Herpes simplex type 1 encephalitis results from
neuronal cell death secondary to viral invasion, and from inflammatory
changes and cerebral oedema secondary to the immune response to the
virus. Corticosteroids could have an important role in the management of
Herpes simplex encephalitis because their anti-inflammatory action
reduces cerebral oedema. However their use has been limited by concerns
that their immunosuppressive actions could increase viral replication
and spread. The present study examined this issue in a rat model in
which injection of HSV-1 into the cervical vagus nerve produced a
well-defined focal encephalitis, characterised by an orderly progression
of the virus through central neural pathways connected with vagal
afferent termination sites in the medulla oblongata. After injection of
HSV-1, rats were treated twice a day, either with vehicle (saline, 400
microl i.p.), with acyclovir (30 mg/kg i.p.), with dexamethasone (5
mg/kg i.p.), or with both acyclovir and dexamethasone. Animals were
sacrificed after 72 h, and viral load in different brain regions was
quantified by computer-assisted measurement of the area occupied by
immunohistochemical reaction product. Treatment with acyclovir reduced
viral load to 17 +/- 5% of the saline value (P < 0.01). After
dexamethasone treatment, the viral load (63 +/- 13% of the saline value)
was also reduced (P < 0.05). Treatment with both acyclovir and
dexamethasone reduced viral load to 26 +/- 8% of the saline value (P <
0.01 compared with saline, and P > 0.05 compared to acyclovir alone).
Our results confirm the effectiveness of acyclovir in a new model of
HSV-1 infection, and provide evidence that corticosteroids do not
inhibit the antiviral action of acyclovir. In addition corticosteroids
may decrease the extent of infection in their own right. The acute time
course studied in our model parallels the time course of acute Herpes
simplex encephalitis in humans. Our data suggests that corticosteroids
are not detrimental when combined with acyclovir in the management of
this condition.
JOURNAL ARTICLE Acyclovir/ADMINISTRATION & DOSAGE
Amygdala/METABOLISM/PATHOLOGY/VIROLOGY Animal Antigens,
Viral/METABOLISM Dexamethasone/*ADMINISTRATION & DOSAGE Disease
Models, Animal Drug Therapy, Combination Encephalitis, Herpes
Simplex/*DRUG THERAPY/PATHOLOGY/VIROLOGY Female Focal Infection/*DRUG
THERAPY/PATHOLOGY/VIROLOGY Herpesvirus 1, Human/*DRUG EFFECTS/GROWTH &
DEVELOPMENT/ PATHOGENICITY Immunohistochemistry Medulla
Oblongata/METABOLISM/PATHOLOGY/VIROLOGY Rats Rats, Inbred F344
Support, Non-U.S. Gov't Vagus Nerve/METABOLISM/VIROLOGY Viral Load
Virus Replication/*DRUG EFFECTS
www.aegis.org